New scSNV-seq technique unveils genetic drivers of diseases like cancer and Alzheimer’s

FHS
March 4, 2024
9:31 am

Scientists have developed a new screening tool to uncover how genetic changes affect gene activity and can lead to diseases such as cancer, autoimmunity, neurodegeneration and cardiovascular disease. This new tool enables the investigation of thousands of DNA mutations identified by genetic studies in one experiment, guiding the development of advanced diagnostics and treatments.

Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full-Year Ended December 31, 2023 – Biotech Investments

Rancho Cucamonga, 02/28/2024 / 13:06, PST/PDT – EQS Newswire – Amphastar Pharmaceuticals, Inc. Reports Net Revenues of $178.1 Million for the Three Months Ended December

February 29, 2024

Denali’s $500M placement; Brain health startup raises $26M

Plus, news about Healis Therapeutics, NRx Pharmaceuticals, and Nuvalent: Denali Therapeutics’ $500M PIPE: The company is selling nearly 30 million shares at $17.06 apiece. Baker

February 28, 2024

Over 80% of women are iron deficient by their third trimester

Iron deficiency is prevalent among pregnant women, impacting health outcomes. This study emphasizes the importance of monitoring and nutrition during pregnancy.

September 30, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.